InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Michael Grosse, Président. Director active across 1 company, notably Sartorius Stedim Biotech. Aggregated, 1 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €158.3m. History available since 10 December 2025. The latest transaction was filed on 10 December 2025 (Cession). Regulator: AMF. The full history is accessible without signup.
Declarations1 total
▼
750,000 shares@ €211.10100.0% of flowActionHors plateforme de négociation2025DD1074245
1 of 1 declaration
About Michael Grosse
Michael Grosse is the Chairman of Sartorius Stedim Biotech, a company specializing in solutions for the biopharmaceutical industry. As chairman, he oversees the company's activities and contributes to its growth strategy. Sartorius Stedim Biotech is recognized for its innovations in the biotechnology field.
